Navigation Links
U.S. Department of State Urged to Support Ban of Mercury in Vaccines
Date:8/18/2011

WASHINGTON, Aug. 18, 2011 /PRNewswire-USNewswire/ -- CoMeD – On Thursday, August 18, 2011, scientists and advocates from the Coalition for Mercury-free Drugs (CoMeD) met with officials from the United States (U.S.) Department of State and other government agencies.  This meeting discussed the inclusion of pharmaceuticals in the upcoming treaty negotiations in Nairobi, Kenya about a global treaty on mercury being developed by the United Nations Environment Programme (UNEP).  CoMeD had previously expressed its gratitude to see pharmaceuticals listed in "Annex C (Mercury-added product not allowed)" of the latest draft of the proposed treaty.

CoMeD, and the international coalition it leads, provided a compendium of the latest evidence for the serious danger represented by the on-going use of mercury in medicine, especially Thimerosal (49.6% mercury by weight) in vaccines as well as the continuing use of mercury-silver-amalgam fillings in dentistry.  Thimerosal, still used as a vaccine preservative and in-process sterilizing agent, is an unnecessary component in several vaccines, including influenza, and a sometimes-undisclosed component in other drugs.  Its use has been repeatedly associated with neurodevelopmental disorders, cancer, birth defects and miscarriage.  Those harmed most by Thimerosal in vaccines are the unborn and the newborn.  Finally, CoMeD explained the feasibility of using 2-phenoxyethanol, a much less toxic, non-bioaccumulative, cost-effective alternative to Thimerosal.

Members of CoMeD declared that, in terms of 21st Century science, medicine, law, and ethics, mercury-based medicines and products are clearly unnecessary bioaccumulative toxic materials, and, as such, they should be immediately banned for the sake of the public health.  CoMeD also explained that, while the U.S. Department of State may lack the power to protect the American public by directly making pharmaceuticals mercury-free, it is within the diplomatic power of the U.S. Department of State to recommend that, by treaty, all pharmaceuticals should be mercury-free.

In 1999, the U.S. Public Health Service and American Academy of Pediatrics called for Thimerosal to be removed from U.S. Thimerosal-preserved vaccines "as soon as possible".  Since then, Thimerosal has been removed from most of the previously Thimerosal-preserved, U.S. vaccines.  Dr. Mark Geier of CoMeD challenged the current inequities in the vaccines provided: "Children around the world, no matter their place of birth or their income level, deserve safe mercury-free vaccines.  The practice of providing mercury-reduced and mercury-free vaccines to developed countries while insisting that developing nations take mercury-preserved ones is wrong."


'/>"/>
SOURCE Coalition for Mercury-Free Drugs (CoMeD)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
2. Agriculture Department Warns Consumers of Tainted Raw Milk Sold by Chester County Dairy
3. U.S. Department of Health and Human Services Completes Funding of 2006 Contract Award to CSCs DVC and Baxter
4. DuPont Provides Technology for Washington Hospital Centers Emergency Department
5. NYC Department of Healths Get Some NYC Condoms Sends Wrong Message and Misuses Tax Dollars, says MIM President Bob Peters
6. PA Department of Health Reports Rise in Flu Activity; Reminds Public of Need for Flu Shot
7. Columbia University Medical Center and Rosetta Genomics Announce Columbia Universitys Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica
8. Agriculture Department Warns Consumers of Tainted Raw Milk Sold by Lebanon County Dairy
9. Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health
10. Justice Department Will Not Oppose CEO Roundtable on Cancers Proposal
11. USD 12.5 m Funding for the Development of Intercells Vaccine Patch System for Pandemic Influenza From U.S. Department of Health and Human Services (HHS)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... Sept. 27, 2017  Commended for their devotion to personalized ... Ranked as number one in the South Florida Business Journal,s ... Inc. 5000 yearly list, the national specialty pharmacy has found ... Bardisa will soon be honored by SFBJ as the ... Set to receive his award in October, Bardisa ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... leader in post-acute health care, have expanded their existing home health joint venture ... , AccentCare has been operating a joint venture home health company with Asante, ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare events ... Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the ... The annual award competition recognizes editorial and design excellence across a range of sectors. ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned ... Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness ... on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry ...
(Date:10/12/2017)... ... 12, 2017 , ... Vohra Chief Medical Officer Dr. Shark ... skilled nursing facility medical directors and other clinicians at various events in October. ... "At many of these conferences we get to educate other physicians, facility nurses, ...
Breaking Medicine News(10 mins):